Clinical Trial Update: Gene Therapy of Pancreatic Ductal Adenocarcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a gene therapy for pancreatic ductal adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Pancreatic Adenocarcinoma | Phase 1 | Status: COMPLETED